<DOC>
	<DOCNO>NCT01396486</DOCNO>
	<brief_summary>The purpose study ) evaluate efficacy omega-3 fatty acid versus inositol treatment pediatric bipolar disorder , b ) evaluate efficacy omega-3 fatty acid plus inositol treatment pediatric bipolar disorder , c ) assess side effect profile omega-3 fatty acid plus inositol . This study 12-week trial child age 5-12 year old bipolar spectrum disorder .</brief_summary>
	<brief_title>Inositol Omega-3 Fatty Acids Pediatric Mania</brief_title>
	<detailed_description>The investigator propose conduct randomize , double blind , control trial evaluate effectiveness tolerability omega-3 fatty acid inositol use alone combination . The investigator plan decrease variability population study limit age range 5-12 year exclude case significant , untreated , comorbidity . The cognitive effects/side effect neuropsychological battery pre post treatment measure . Subjects history fail treatment two conventional treatment exclude . This 12-week , double-blind , randomized clinical trial study compare efficacy tolerability natural treatment omega-3 fatty acid inositol use combination treatment bipolar spectrum disorder child adolescent ( age 5-12 ) . Subjects randomize double blind fashion one three arm : omega-3 fatty acid , inositol combine treatment . Further , propose study include measure cognition prior start study medication endpoint . The investigator minimize variability population study limit age range 5-12 year , minimize untreated clinically significant comorbidity exclude subject already fail treatment 2 anti-manic agent . Subjects include youth age 5-12 year bipolar spectrum disorder ( type I , II , NOS ) , mixed , manic , hypomanic state , accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( American Psychiatric Association , 2000 ) ( DSM-IV ) , randomize 3 treatment arm : 1 ) treatment omega-3 fatty acid ( N=20 ) ; 2 ) treatment inositol ( N=20 ) ; 3 ) treatment combination inositol omega-3 fatty acid ( N=20 ) .</detailed_description>
	<mesh_term>Inositol</mesh_term>
	<criteria>1 . Male female subject , 512 year age . 2 . Subjects must DSMIV diagnosis bipolar spectrum disorder ( type I , II , Not Otherwise Specified ( NOS ) ) , currently display mixed , manic , hypomanic symptom ( without psychotic feature ) accord DSMIV base clinical assessment confirm structured diagnostic interview ( Schedule Affective Disorders Schizophrenia SchoolAge Children Epidemiological Version ( KSADSE ) ) ( Orvaschel , 1994 ) . 3 . Subjects legal representative must level understanding sufficient communicate intelligently investigator study coordinator , cooperate test examination require protocol . 4 . Subjects legal representative must consider reliable . 5 . Each subject his/her authorized legal representative must understand nature study . The subject 's authorized legal representative must sign informed consent document subject must sign informed assent document . 6 . Subjects must initial score YMRS total score least 20 . 7 . Subject must able swallow pill . 8 . Subjects ADHD ODD allow participate study provide impairment associate disorder mild moderate severity ( severe ) milder severity relative impairment bipolar disorder , accord clinician evaluation . Subjects comorbid anxiety disorder allow participate provide impairment associate anxiety minimal severity , accord clinician evaluation . Subjects comorbid CD exclude . 1 . Investigator his/her immediate family ; define investigator 's spouse , parent , child , grandparent , grandchild . 2 . Serious unstable illness include hepatic , renal , gastroenterological , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease . 3 . History bleed diathesis , include von Willebrand disease . 4 . Uncorrected hypothyroidism hyperthyroidism . 5 . History sensitivity omega3 fatty acid inositol . A nonresponder history intolerance omega3 fatty acid inositol , 2 month treatment adequate dos determine clinician . 6 . Severe allergy multiple adverse drug reaction . 7 . Failed 2 previous trial antimanic treatment include lithium , anticonvulsant atypical antipsychotic medication . 8 . Current past history seizure . 9 . DSMIV substance use , abuse dependence ( unlikely age 512 ) . 10 . Judged clinically serious suicidal risk . 11 . Current diagnosis schizophrenia . 12 . Current diagnosis conduct disorder 13 . Pregnancy ( unlikely age 512 ) . 14 . YMRS Item # 8 ( Content ) score 8 ( `` delusion ; hallucination '' ) . 15 . YMRS total score 40 . 16 . Girls begin menstruate . 17 . CSSRS score â‰¥ 4 . 18 . IQ &lt; 70 .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Omega-3 Fatty Acids</keyword>
	<keyword>Fish Oil</keyword>
	<keyword>Inositol</keyword>
	<keyword>Natural supplement</keyword>
	<keyword>Bipolar Spectrum Disorders</keyword>
	<keyword>Mania</keyword>
	<keyword>Depression</keyword>
	<keyword>Children</keyword>
</DOC>